Search

Your search keyword '"Ip, Michael S"' showing total 478 results

Search Constraints

Start Over You searched for: Author "Ip, Michael S" Remove constraint Author: "Ip, Michael S"
478 results on '"Ip, Michael S"'

Search Results

8. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

14. Retinal Venous Occlusive Disease

15. Macular spatial distribution of preserved autofluorescence in patients with choroideremia

18. Final Outcomes from the Randomized RECOVERY Trial of Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy

19. Longitudinal Changes in Scotopic and Mesopic Macular Function as Assessed with Microperimetry in Patients With Stargardt Disease: SMART Study Report No. 2

24. SCORE2 Report 2 Study Design and Baseline Characteristics

27. Central Retinal Vein Occlusion

29. Faster Sensitivity Loss around Dense Scotomas than for Overall Macular Sensitivity in Stargardt Disease: ProgStar Report No. 14

30. Reply

31. Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy: Outcomes from the Randomized RECOVERY Trial

34. Efficacy and Safety of Brolucizumab for Diabetic Macular Edema

35. Longitudinal Changes of Fixation Location and Stability Within 12 Months in Stargardt Disease: ProgStar Report No. 12

37. Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema

38. Geographic Atrophy Management Consensus (GA-MAC): a Delphi panel study on identification, diagnosis and treatment

40. Measurement and Reproducibility of Preserved Ellipsoid Zone Area and Preserved Retinal Pigment Epithelium Area in Eyes With Choroideremia

44. Considerations for the Identification and Management of Geographic Atrophy: Recommendations from an Expert Panel.

46. High Variation in Inner Retinal Reflectivity Predicts Poor Visual Outcome in Patients With Central Retinal Vein Occlusion: SCORE2 Report 21

50. One-Year Real-World Brolucizumab Outcomes in Neovascular Age-Related Macular Degeneration from a Large US Cohort in the IRIS® Registry

Catalog

Books, media, physical & digital resources